Citigroup Inc. vs Pfizer Inc.
Side-by-side earnings signal comparison from SEC quarterly filings
Verdict
Citigroup Inc. (C) carries a "Tailwind" signal with +10.3% revenue growth, while Pfizer Inc. (PFE) is "Neutral" with -18.4% revenue growth. Both companies report in the Financials and Healthcare sectors.
| Metric | Citigroup Inc. (C) | Pfizer Inc. (PFE) |
|---|---|---|
| Operator Signal | Tailwind | Neutral |
| Signal Confidence | HIGH | HIGH |
| Latest Revenue | $22.1B | $14.5B |
| Revenue Growth | 10.3%* | -18.4% |
| Latest EPS | $1.86* | $0.47 |
| EPS Growth | 22.4%* | -39.7% |
| Sector | Financials | Healthcare |
| Quarters Tracked | 8 | 8 |
Citigroup Inc. (C) carries a "Tailwind" signal with +10.3% revenue growth, while Pfizer Inc. (PFE) is "Neutral" with -18.4% revenue growth. Both companies report in the Financials and Healthcare sectors.